Nondopaminergic neurons in Parkinson's disease.
Hirsch
E C
EC
Inserm U289, Department of Experimental Neurology and Therapeutics, Hôpital de la Salpêtrière, Paris, France.
Orieux
G
G
Muriel
M-P
MP
Francois
C
C
Feger
J
J
D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D015536:Down-Regulation / Q000502:physiology; D004351:Drug Resistance / Q000502:physiology; D006801:Humans; D009434:Neural Pathways / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D009474:Neurons / Q000378:metabolism* / Q000473:pathology / Q000648:ultrastructure; D018377:Neurotransmitter Agents / Q000172:deficiency*; D010300:Parkinson Disease / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D011954:Receptors, Dopamine / Q000378:metabolism / Q000648:ultrastructure; D015854:Up-Regulation / Q000502:physiology
D018377:Neurotransmitter Agents; D011954:Receptors, Dopamine